Alerts will be sent to your verified email
Verify Email
NEPHROCARE
|
Nephro Care India
|
Aspira Pathlab&Diagn
|
Chandan Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
143.87 % | -3.47 % | 14.17 % |
|
5yr average Equity Multiplier
|
18.06 | 1.42 | 2.9 |
|
5yr Average Asset Turnover Ratio
|
1.28 | 1.0 | 1.36 |
|
5yr Avg Net Profit Margin
|
8.51 % | -3.89 % | 4.66 % |
|
Price to Book
|
4.66 | 5.26 | 6.75 |
|
P/E
|
68.41 | 26.76 | 37.34 |
|
5yr Avg Cash Conversion Cycle
|
-60.13 Days | -26.26 Days | 9.38 Days |
|
Inventory Days
|
6.87 Days | 10.15 Days | 27.59 Days |
|
Days Receivable
|
13.4 Days | 38.11 Days | 59.72 Days |
|
Days Payable
|
75.6 Days | 81.06 Days | 159.41 Days |
|
5yr Average Interest Coverage Ratio
|
32.99 | 0.45 | 5.07 |
|
5yr Avg ROCE
|
25.8 % | -0.04 % | 20.92 % |
|
5yr Avg Operating Profit Margin
|
13.74 % | 6.02 % | 10.41 % |
|
5 yr average Debt to Equity
|
10.46 | 0.1 | 0.68 |
|
5yr CAGR Net Profit
|
109.59 % | n/a | n/a |
|
5yr Average Return on Assets
|
12.63 % | -2.37 % | 5.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.47 % | 18.39 % | 49.47 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | -16.16 % | 0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Nephro Care India
|
Aspira Pathlab&Diagn
|
Chandan Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|